Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)
Research with induced pluripotent stem cells (iPSCs) involves specific ethical challenges, which should be addressed in the informed consent process. Up to now, little concern has been paid to the practice of information in iPSC-clinical studies. In order to fill this research gap, we have searched...
Main Authors: | Marcin Orzechowski, Maximilian Schochow, Michael Kühl, Florian Steger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.627816/full |
Similar Items
-
Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
by: Marcin Orzechowski, et al.
Published: (2020-03-01) -
Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
by: Eunhye Kim, et al.
Published: (2016-09-01) -
Induced Pluripotent Stem Cells (iPSCs)—Roles in Regenerative Therapies, Disease Modelling and Drug Screening
by: Mourad A. M. Aboul-Soud, et al.
Published: (2021-09-01) -
Human Fibrinogen for Maintenance and Differentiation of Induced Pluripotent Stem Cells in Two Dimensions and Three Dimensions
by: Jarel K. Gandhi, et al.
Published: (2019-06-01) -
Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) at naïve state
by: Yixuan Wang, et al.
Published: (2018-01-01)